ArticleBioinformatics (Oxford, England)2025
A conditional denoising VAE-based framework for antimicrobial peptides generation with preserving desirable properties.
Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Deep Generative Models for the Discovery of Antiviral Peptides Targeting Dengue Virus: A Systematic Review.International journal of molecular sciences · 2025Pooled it
- Dual Activity Microbial Peptides Catalog.Scientific data · 2026Article
- Artificial Intelligence-Driven Discovery and Optimization of Antimicrobial Peptides Targeting ESKAPE Pathogens and Multidrug-Resistant Fungi.Microorganisms · 2026Review
- Peptide-based drug design using generative AI.Chemical communications (Cambridge, England) · 2026Review
- Antibacterial hydrogels for skin infected wounds: frontier approaches as antibiotic alternatives therapy.Frontiers in cellular and infection microbiology · 2026Review
- Article
- Harnessing Machine Learning Approaches for the Identification, Characterization, and Optimization of Novel Antimicrobial Peptides.Antibiotics (Basel, Switzerland) · 2025Review
- A novel generative framework for designing pathogen-targeted antimicrobial peptides with programmable physicochemical properties.PLoS computational biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationThe widespread use of antibiotics has led to the emergence of resistant pathogens. Antimicrobial peptides (AMPs) combat bacterial infections by disrupting the integrity of cell membranes, making it challenging for bacteria to develop resistance. Consequently, AMPs offer a promising solution to addressing antibiotic resistance. However, the limited availability of natural AMPs cannot meet the growing demand. While deep learning technologies have advanced AMP generation, conventional models often lack stability and may introduce unforeseen side effects.
resultsThis study presents a novel denoising VAE-based model guided by desirable physicochemical properties for AMP generation. The model integrates key features (e.g. molecular weight, isoelectric point, hydrophobicity, etc.), and employs position encoding along with a Transformer architecture to enhance generation accuracy. A customized loss function, combining reconstruction loss, KL divergence, and property preserving loss ensure effective model training. Additionally, the model incorporates a denoising mechanism, enabling it to learn from perturbed inputs, thus maintaining performance under limited training data. Experimental results demonstrate that the proposed model can generate AMPs with desirable functional properties, offering a viable approach for AMP design and analysis, which ultimately contributes to the fight against antibiotic resistance. AVAILABILITY AND IMPLEMENTATION: The data and source codes are available both in GitHub (https://github.com/David-WZhao/PPGC-DVAE) and Zenodo (DOI 10.5281/zenodo.14730711).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.